Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Rectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00004891
What this trial is testing

PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center 149
Not applicableStudy completedNCT00593073
What this trial is testing

Use of Novel Tailored Reminders in Rural Primary Care

Who this might be right for
Colorectal Cancer
University of Kansas 707
Not applicableLooking for participantsNCT06787625
What this trial is testing

Development of Organoids From Primary Colorectal Tumors and Synchronous Liver Metastases

Who this might be right for
Colo-rectal Cancer
Regina Elena Cancer Institute 10
Not applicableUnknownNCT03668418
What this trial is testing

Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos

Who this might be right for
Liver CancerPancreatic CancerGastric Cancer+4 more
University of Pisa 120
Not applicableUnknownNCT06339346
What this trial is testing

Analysis of Histopathological Factors Predictive of Lymph Node Involvement and Management Practices in pT1 Colorectal Cancers Treated by Primary Endoscopic Resection

Who this might be right for
Colorectal CancerColorectal Adenocarcinoma
University Hospital, Brest 400
Not applicableUnknownNCT05051592
What this trial is testing

Role of Circulating Tumour DNA Testing in Assessing for Alterations of Primary Anti-EGFR Resistance in RAS/RAF Wild-type Metastatic Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer
National University Hospital, Singapore 40
Early research (Phase 1)Ended earlyNCT02933944
What this trial is testing

Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer

Who this might be right for
Rectal Cancer
Targovax ASA 6
Testing effectiveness (Phase 2)Study completedNCT01806675
What this trial is testing

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more
Sanjiv Sam Gambhir 25
Not applicableLooking for participantsNCT03823144
What this trial is testing

Intravital Microscopy in Human Solid Tumors

Who this might be right for
Solid Tumor, AdultClinical Stage IV Gastric Cancer AJCC v8Malignant Solid Neoplasm+20 more
Mayo Clinic 85
Testing effectiveness (Phase 2)Ended earlyNCT02859415
What this trial is testing

Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases

Who this might be right for
Esophageal NeoplasmsLung NeoplasmsMesothelioma+2 more
National Cancer Institute (NCI) 3
Not applicableWithdrawnNCT06098755
What this trial is testing

The Sequestration of Holistic Stress Management Techniques for Adults

Who this might be right for
Stress, JobPTSDHypervigilance+24 more
Goddess Zena I. Jones
Early research (Phase 1)Study completedNCT01254617
What this trial is testing

Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer

Who this might be right for
Recurrent Colon CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+39 more
National Cancer Institute (NCI) 24
Not applicableStudy completedNCT00724503
What this trial is testing

FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal CarcinomaLiver Metastases
Sirtex Medical 530
Not applicableStudy completedNCT00900094
What this trial is testing

UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer

Who this might be right for
Breast CancerColorectal CancerEsophageal Cancer+4 more
University of Michigan Rogel Cancer Center 200
Early research (Phase 1)Study completedNCT00094003
What this trial is testing

Study of NS-9 in Patients With Liver Metastases

Who this might be right for
Liver NeoplasmsNeoplasm MetastasisLocal Neoplasm Recurrences
NS Pharma, Inc. 20
Not applicableStudy completedNCT00544336
What this trial is testing

Family Quality of Life Among Families With a Member Who is a Cancer Patient

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+3 more
Vanderbilt-Ingram Cancer Center 366
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Not applicableLooking for participantsNCT06827366
What this trial is testing

Lifestyle Intervention Among Participants of the French Colorectal Cancer Screening Program (LIFE-SCREEN)

Who this might be right for
Colorectal Cancer ScreeningColorectal Cancer PreventionColorectal Cancer
Centre Leon Berard 800
Not applicableStudy completedNCT01468675
What this trial is testing

Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care

Who this might be right for
Colorectal CancerBreast CancerCoronary Heart Disease+1 more
Brigham and Women's Hospital 6,075
Not applicableApproved For MarketingNCT04100694
What this trial is testing

Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor

Who this might be right for
NRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more
Merus B.V.
Next Page